JP2012509919A5 - - Google Patents

Download PDF

Info

Publication number
JP2012509919A5
JP2012509919A5 JP2011537896A JP2011537896A JP2012509919A5 JP 2012509919 A5 JP2012509919 A5 JP 2012509919A5 JP 2011537896 A JP2011537896 A JP 2011537896A JP 2011537896 A JP2011537896 A JP 2011537896A JP 2012509919 A5 JP2012509919 A5 JP 2012509919A5
Authority
JP
Japan
Prior art keywords
calcium sulfate
cmc
calculated
composition
sodium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011537896A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012509919A (ja
JP5702294B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2009/008496 external-priority patent/WO2010060644A1/en
Publication of JP2012509919A publication Critical patent/JP2012509919A/ja
Publication of JP2012509919A5 publication Critical patent/JP2012509919A5/ja
Application granted granted Critical
Publication of JP5702294B2 publication Critical patent/JP5702294B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011537896A 2008-11-27 2009-11-27 一以上の生物吸収性セラミックを含む組成物の吐出性および凝固時間を制御するための、カルボキシメチルセルロースの使用 Active JP5702294B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA200801674 2008-11-27
DKPA200801674 2008-11-27
PCT/EP2009/008496 WO2010060644A1 (en) 2008-11-27 2009-11-27 Use of carboxymethylcellulose to control ejectability and solidification of time of compositions one or more bioresorbable ceramics

Publications (3)

Publication Number Publication Date
JP2012509919A JP2012509919A (ja) 2012-04-26
JP2012509919A5 true JP2012509919A5 (cg-RX-API-DMAC7.html) 2013-01-24
JP5702294B2 JP5702294B2 (ja) 2015-04-15

Family

ID=40823443

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011537896A Active JP5702294B2 (ja) 2008-11-27 2009-11-27 一以上の生物吸収性セラミックを含む組成物の吐出性および凝固時間を制御するための、カルボキシメチルセルロースの使用

Country Status (14)

Country Link
US (1) US9198884B2 (cg-RX-API-DMAC7.html)
EP (1) EP2376135B1 (cg-RX-API-DMAC7.html)
JP (1) JP5702294B2 (cg-RX-API-DMAC7.html)
KR (1) KR101632430B1 (cg-RX-API-DMAC7.html)
CN (1) CN102227228A (cg-RX-API-DMAC7.html)
AU (1) AU2009319348B2 (cg-RX-API-DMAC7.html)
CA (1) CA2744141C (cg-RX-API-DMAC7.html)
DK (1) DK2376135T3 (cg-RX-API-DMAC7.html)
ES (1) ES2545962T3 (cg-RX-API-DMAC7.html)
IL (1) IL212624A (cg-RX-API-DMAC7.html)
MX (1) MX2011005243A (cg-RX-API-DMAC7.html)
RU (1) RU2536415C2 (cg-RX-API-DMAC7.html)
WO (1) WO2010060644A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA201103805B (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105727370B (zh) * 2016-02-18 2018-11-06 江苏西宏生物医药有限公司 一种注射植入剂
US11752099B2 (en) 2017-03-27 2023-09-12 W. L. Gore & Associates, Inc. Injectable and biodegradable polymer formulations for controlled release of bioactive agents

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB999487A (en) * 1963-05-03 1965-07-28 Ici Ltd Set-retarded calcium sulphate hemihydrate
US3891453A (en) * 1973-07-26 1975-06-24 United States Gypsum Co Asbestos-free joint compounds
GB1506897A (en) * 1975-11-05 1978-04-12 Ici Ltd Method of securing fixing elements in rock
JPS5626756A (en) * 1979-08-10 1981-03-14 Sato Hironobu Manufacture of alpha gypsum
HU197207B (en) * 1985-12-04 1989-03-28 Chinoin Gyogyszer Es Vegyeszet Process for producing pharmaceutical comprising 1-(3',4'-diethoxybenzyl)-6,7-diethoxy-3,4-dihydro-isoquinolinium-theophylline-7-acetate or its monohydrate as active ingredient
CA2268156C (en) 1996-10-16 2007-05-29 Etex Corporation Bioceramic compositions
JP2000264710A (ja) * 1999-03-23 2000-09-26 Mitsui Chemicals Inc 型材用流し込み組成物
CA2378486A1 (en) 1999-08-05 2001-02-15 Takashi Kurasawa Osteogenesis promoter sustained-release paste
US7371409B2 (en) * 2001-09-06 2008-05-13 Wright Medical Technology, Inc. Bone graft substitute composition
US7291179B2 (en) * 2002-06-24 2007-11-06 Wright Medical Technology, Inc. Bone graft substitute composition
US6652887B1 (en) * 2002-06-24 2003-11-25 Wright Medical Technology, Inc. Bone graft substitute composition
AU2002335562B2 (en) * 2002-09-30 2007-07-05 Regen Biotech, Inc. Bone-filling composition for stimulating bone-forming and bone-consolidation comprising calcium sulfate and viscous biopolymers
WO2004108625A1 (en) * 2003-06-05 2004-12-16 Borden Chemical, Inc. Gypsum products and method for their manufacture
PL1680089T3 (pl) * 2003-10-22 2014-03-31 Lidds Ab Kompozycja zawierająca biodegradowalną ceramikę hydratującą do kontrolowanego dostarczania leków
US7671012B2 (en) * 2004-02-10 2010-03-02 Biosurface Engineering Technologies, Inc. Formulations and methods for delivery of growth factor analogs
KR20140014294A (ko) * 2005-03-31 2014-02-05 리드스 에이비 유효 물질의 국소 전달을 기본으로 하는 전립선 질병의 치료 방법
AU2007224651B8 (en) * 2006-03-14 2011-10-27 Lidds Ab Bioresorbable controlled-release composition
DE102008022086A1 (de) * 2008-05-05 2009-11-12 Schulz, Hans H. Zweikomponenten-Alginat

Similar Documents

Publication Publication Date Title
CN101828550B (zh) 复合过一硫酸氢钾消毒片的组成及其制备工艺
CN102350298A (zh) 一种净水用的多功能复合吸附材料及其制备方法
JP2011500711A5 (cg-RX-API-DMAC7.html)
WO2011161056A3 (en) Dialysis precursor composition
WO2007122580A3 (en) Compositions of phenylephrine useful for treatment of respiratory illness
BR112014005286A2 (pt) composições, métodos, e sistemas para a síntese e uso de agentes de imageamento
PE20080331A1 (es) Composiciones farmaceuticas estabilizadas que comprenden fesoterodina
WO2011056985A3 (en) Substituted heterocyclic compounds
RU2013151904A (ru) Применение соединений мышьяка для лечения отторжения ткани или органа
JP2008534546A5 (cg-RX-API-DMAC7.html)
CL2013001459A1 (es) Compuestos derivados de quinazolincarboxamida azetidina; proceso para prepararlos; composicion farmaceutica que los comprende; set (kit); y su uso para el tratamiento de enfermedades hiperproliferativas tales como cancer, inflamacion, pancreatitis o enfermedad renal, dolor, hiperplasia benigna de piel entre otras.
TW201129386A (en) Microcrystalline cellulose and calcium phosphate compositions useful as pharmaceutical excipients
JP2021500092A5 (cg-RX-API-DMAC7.html)
CN106317999B (zh) 一种释放负氧离子的脱硫石膏腻子
JP2013544892A5 (cg-RX-API-DMAC7.html)
CN101658170B (zh) 一种用于混凝土所使用的聚羧酸减水剂的防腐剂
JP2010514556A5 (cg-RX-API-DMAC7.html)
JP2009514786A5 (cg-RX-API-DMAC7.html)
BR112012005667A2 (pt) '' agente fluorescente particulado topoespec´fico, composição detergente, composição cosmética, processos de preparação de um agente fluorescente particulado bipolar, uso de uma particula de argila de uso de um agente fluorescente particulado''
RU2013152229A (ru) Составы 2-иминобиотина и их применение
JP2009149532A5 (cg-RX-API-DMAC7.html)
WO2011063775A3 (en) Pectin complexes of sartans and pharmaceutical compositions based thereon
WO2008040987A3 (en) Biocidal formulation
JP2006182655A5 (cg-RX-API-DMAC7.html)
RU2011126176A (ru) Применение карбоксиметилцеллюлозы для контроля выдавливаемости и времени затвердения композиций, содержащих один или более керамических материалов